HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin-Wen Chen Selected Research

DNA (Deoxyribonucleic Acid)

5/2023Prenatal diagnosis and molecular genetic analysis of recurrent trisomy 18 of maternal origin in two consecutive pregnancies.
5/2023Low-level mosaic trisomy 9 at amniocentesis in a pregnancy associated with a favorable fetal outcome, intrauterine growth restriction, cytogenetic discrepancy between cultured amniocytes and uncultured amniocytes and perinatal progressive decrease of the aneuploid cell line.
5/2023Low-level mosaic trisomy 9 at amniocentesis associated with a positive non-invasive prenatal testing for trisomy 9, maternal uniparental disomy 9, intrauterine growth restriction and a favorable fetal outcome in a pregnancy.
3/2023Low-level mosaic trisomy 15 at amniocentesis without uniparental disomy 15 in a pregnancy associated with cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes, a favorable fetal outcome and perinatal decrease of the aneuploid cell line.
3/2023Mosaic 45,X/46, XX at amniocentesis with high-level mosaicism for 45,X in a pregnancy with a favorable fetal outcome and postnatal decrease of the 45,X cell line.
3/2023Low-level mosaic trisomy 17 at amniocentesis in a pregnancy associated with a favorable fetal outcome and cytogenetic discrepancy between cultured and uncultured amniocytes.
3/2023Low-level mosaic trisomy 13 at amniocentesis in a pregnancy associated with a favorable fetal outcome and cytogenetic discrepancy in various tissues.
1/2023Mosaic tetrasomy 9p at amniocentesis in a pregnancy associated with a favorable fetal outcome, perinatal progressive decrease of the aneuploid cell line and cytogenetic discrepancy in various tissues.
1/2023Mosaic trisomy 21 at amniocentesis in a twin pregnancy associated with a favorable fetal outcome, maternal uniparental disomy 21 and postnatal decrease of the trisomy 21 cell line.
1/2023Mosaic trisomy 21 at amniocentesis associated with a favorable fetal outcome and perinatal progressive decrease of the trisomy 21 cell line.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin-Wen Chen Research Topics

Disease

30Uniparental Disomy
05/2023 - 04/2017
15Down Syndrome (Down's Syndrome)
01/2023 - 02/2017
6Trisomy (Trisomies)
05/2023 - 09/2020
5Fetal Growth Retardation (Intrauterine Growth Retardation)
05/2023 - 10/2017
5Trisomy 13 Syndrome
11/2022 - 12/2017
4Trisomy 18 Syndrome
05/2023 - 07/2020
2Aneuploidy (Aneuploid)
11/2022 - 07/2021
2Ring Chromosomes (Ring Chromosome)
03/2022 - 08/2017
2Pre-Eclampsia (Preeclampsia)
03/2022 - 01/2022
2Chromosome Aberrations (Chromosome Abnormalities)
05/2021 - 01/2020
2Spontaneous Abortion (Miscarriage)
09/2020 - 06/2017
2Oligohydramnios
09/2020 - 11/2019
2Ventricular Heart Septal Defects (Ventricular Septal Defect)
09/2019 - 06/2016
1Cystic Lymphangioma (Hygroma)
05/2023
1Turner Syndrome (Turner's Syndrome)
03/2023
1tetrasomy 9p Chromosome 9
01/2023
1Congenital Heart Defects (Congenital Heart Defect)
11/2022
1Male Infertility (Male Sterility)
09/2022
1Fetal Distress
03/2021
1Persistent Left Superior Vena Cava
03/2021
1Esophageal Atresia
03/2021
1Polyhydramnios
03/2021
115q24 Microdeletion
05/2020
1Pericardial Effusion
09/2019
1Cardiomegaly (Heart Hypertrophy)
09/2019
1Triploidy
12/2018
1Duplication 15q11-q13 Syndrome
10/2018
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
02/2018
1Isochromosomes
12/2017
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
12/2016
1Intellectual Disability (Idiocy)
12/2016
1Obesity
12/2016
1Language Development Disorders (Semantic-Pragmatic Disorder)
06/2016

Drug/Important Bio-Agent (IBA)

40Genetic Markers (Genetic Marker)IBA
05/2023 - 06/2016
18DNA (Deoxyribonucleic Acid)IBA
05/2023 - 10/2018
12dimemorfan (AT 17)IBA
03/2023 - 02/2017
10dichlorobis(azomycin)platinum IIIBA
05/2023 - 10/2017
7Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA
01/2023 - 09/2020
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2023 - 11/2021
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
05/2020
1Cholesterol Side-Chain Cleavage Enzyme (CYP11A1)IBA
05/2020
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
05/2020
1OligonucleotidesIBA
12/2017

Therapy/Procedure

3Ligation
03/2023 - 07/2022
2Cesarean Section (Caesarean Section)
03/2021 - 09/2020
1Treatment Delay
09/2022
1Gastric Balloon
03/2021